Douglas J. O'Dowd
Directeur Financier/CFO chez Xcelience LLC
Provenance du réseau au premier degré de Douglas J. O'Dowd
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Xcelience LLC
 Xcelience LLC Pharmaceuticals: MajorHealth Technology Xcelience LLC provides drug development and manufacturing solutions. Its services include preformulation, analytical development services, release and stability testing, formulation development, gmp manufacturing, small-scale commercial manufacturing and global clinical supplies packaging. The company was founded by Derek G. Hennecke in 2006 and is headquartered in Tampa, FL.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Douglas J. O'Dowd via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Colorado State University | College/University | Undergraduate Degree | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| DSM Life Sciences Products | Corporate Officer/Principal | ||
International Society for Pharmaceutical Engineering
 International Society for Pharmaceutical Engineering Miscellaneous Commercial ServicesCommercial Services The International Society for Pharmaceutical Engineering is a nonprofit association that focuses on scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle. The non-profit company is based in Tampa, FL. The company engages with all levels of regulators to ensure that their education, training, document development, and interpretation are cutting-edge and focused on enabling the production and supply of therapies and devices with unmatched levels of flow, efficiency, and quality sustainably and at scale. John Bournas has been the CEO of the company since 2015. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| The American Academy of Political & Social Science | Corporate Officer/Principal |
Statistiques
Internationale
| Etats-Unis | 6 |
| Pays-Bas | 2 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Opérationnelle
| Corporate Officer/Principal | 7 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
| Chief Operating Officer | 1 |
Relations les plus connectées
- Bourse
- Insiders
- Douglas J. O'Dowd
- Connexions Sociétés
